ZNTL

Zentalis Pharmaceuticals, Inc.

• Reuters·5d ago

  Zentalis grants inducement stock options for 36,000 shares to new hires

• Reuters·5d ago

  ZENTALIS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

• TipRanks·03/28 03:56

  Wedbush Keeps Their Hold Rating on Zentalis Pharmaceuticals (ZNTL)

• TipRanks·03/28 03:55

  Advancing Azenosertib Pipeline and DENALI Readouts Underpin Buy Rating on Zentalis Pharmaceuticals

• NASDAQ·03/27 18:13

  Friday Sector Laggards: Manufacturing, Biotechnology Stocks

• TipRanks·03/27 16:30

  Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX), Zentalis Pharmaceuticals (ZNTL) and Autolus Therapeutics (AUTL)

• Dow Jones·03/27 12:57

  Zentalis Pharmaceuticals Price Target Maintained With a $6.00/Share by Guggenheim

• Benzinga·03/27 12:47

  Guggenheim Reiterates Buy on Zentalis Pharma, Maintains $6 Price Target

• TipRanks·03/27 12:35

  Zentalis Pharmaceuticals (ZNTL) Receives a Buy from Oppenheimer

• TipRanks·03/27 10:30

  Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Nuvation Bio (NUVB) and BioAge Labs, Inc. (BIOA)

• Benzinga·03/26 20:39

  Zentalis Pharma Q4 EPS $(0.49) Misses $(0.44) Estimate.

• Seeking Alpha·03/26 20:33

  Zentalis Pharmaceuticals GAAP EPS of -$1.91

• Reuters·03/26 20:25

  Zentalis Pharmaceuticals FY2025 targets ASPENOVA Phase 3 trial start in 1H 2026; cash climbs to $246 million

• Dow Jones·03/26 20:17

  *Zentalis Pharmaceuticals On Track to Initiate the ASPENOVA Phase 3, Randomized, Confirmatory Trial in 1H 2026 >ZNTL

• Dow Jones·03/26 20:17

  *Zentalis Pharmaceuticals On Track for DENALI Part 2a Dose Confirmation in 1H 2026 >ZNTL